Published in J Bone Miner Res on April 01, 2003
Paxillin is a target for somatic mutations in lung cancer: implications for cell growth and invasion. Cancer Res (2008) 1.60
Autoimmune manifestations in aged mice arise from early-life immune dysregulation. Sci Transl Med (2016) 1.40
GIT1 utilizes a focal adhesion targeting-homology domain to bind paxillin. Cell Signal (2007) 1.23
Integrin αvβ3 and CD44 pathways in metastatic prostate cancer cells support osteoclastogenesis via a Runx2/Smad 5/receptor activator of NF-κB ligand signaling axis. Mol Cancer (2012) 1.02
Diverse roles for the paxillin family of proteins in cancer. Genes Cancer (2012) 0.98
The LIM protein leupaxin is enriched in smooth muscle and functions as an serum response factor cofactor to induce smooth muscle cell gene transcription. Circ Res (2008) 0.90
Caspase-3 regulates catalytic activity and scaffolding functions of the protein tyrosine phosphatase PEST, a novel modulator of the apoptotic response. Mol Cell Biol (2006) 0.88
Regulation of sealing ring formation by L-plastin and cortactin in osteoclasts. J Biol Chem (2010) 0.88
Leupaxin is similar to paxillin in focal adhesion targeting and tyrosine phosphorylation but has distinct roles in cell adhesion and spreading. Cell Adh Migr (2011) 0.87
Role of protein-tyrosine phosphatases in regulation of osteoclastic activity. Cell Mol Life Sci (2009) 0.82
A small molecule that inhibits the interaction of paxillin and alpha 4 integrin inhibits accumulation of mononuclear leukocytes at a site of inflammation. J Biol Chem (2010) 0.82
Focal adhesion kinases in adhesion structures and disease. J Signal Transduct (2012) 0.81
Leupaxin stimulates adhesion and migration of prostate cancer cells through modulation of the phosphorylation status of the actin-binding protein caldesmon. Oncotarget (2015) 0.75
Wnt-dependent beta-catenin signaling is activated after unilateral ureteral obstruction, and recombinant secreted frizzled-related protein 4 alters the progression of renal fibrosis. J Am Soc Nephrol (2005) 2.27
The mechanism of phosphorus as a cardiovascular risk factor in CKD. J Am Soc Nephrol (2008) 1.99
Vascular calcification in chronic kidney disease. Am J Kidney Dis (2004) 1.81
MicroRNA-19a mediates the suppressive effect of laminar flow on cyclin D1 expression in human umbilical vein endothelial cells. Proc Natl Acad Sci U S A (2010) 1.80
The IkappaB kinase (IKK) inhibitor, NEMO-binding domain peptide, blocks osteoclastogenesis and bone erosion in inflammatory arthritis. J Biol Chem (2004) 1.72
Low turnover osteodystrophy and vascular calcification are amenable to skeletal anabolism in an animal model of chronic kidney disease and the metabolic syndrome. J Am Soc Nephrol (2005) 1.54
Impaired micro-RNA pathways diminish osteoclast differentiation and function. J Biol Chem (2008) 1.53
Plasma Dickkopf1 (DKK1) concentrations negatively associate with atherosclerotic calcified plaque in African-Americans with type 2 diabetes. J Clin Endocrinol Metab (2012) 1.52
RGS4, a GTPase activator, improves renal function in ischemia-reperfusion injury. Kidney Int (2011) 1.51
Marrow stromal cells and osteoclast precursors differentially contribute to TNF-alpha-induced osteoclastogenesis in vivo. J Immunol (2004) 1.50
A microRNA expression signature of osteoclastogenesis. Blood (2011) 1.49
BMP-7 is an efficacious treatment of vascular calcification in a murine model of atherosclerosis and chronic renal failure. J Am Soc Nephrol (2003) 1.45
Suppression of pro-inflammatory adhesion molecules by PPAR-delta in human vascular endothelial cells. Arterioscler Thromb Vasc Biol (2007) 1.45
Plasma FGF23 and Calcified Atherosclerotic Plaque in African Americans with Type 2 Diabetes Mellitus. Am J Nephrol (2015) 1.42
Akt1/Akt2 and mammalian target of rapamycin/Bim play critical roles in osteoclast differentiation and survival, respectively, whereas Akt is dispensable for cell survival in isolated osteoclast precursors. J Biol Chem (2004) 1.40
CKD accelerates development of neointimal hyperplasia in arteriovenous fistulas. J Am Soc Nephrol (2009) 1.40
Reversal of the adynamic bone disorder and decreased vascular calcification in chronic kidney disease by sevelamer carbonate therapy. J Am Soc Nephrol (2006) 1.37
Vitamin D receptor activators can protect against vascular calcification. J Am Soc Nephrol (2008) 1.35
Cutting edge: IL-4-mediated protection of primary B lymphocytes from apoptosis via Stat6-dependent regulation of glycolytic metabolism. J Immunol (2007) 1.30
NF-kB signaling blockade abolishes implant particle-induced osteoclastogenesis. J Orthop Res (2004) 1.30
Bone morphogenic protein-7 (BMP-7), a novel therapy for diabetic nephropathy. Kidney Int (2003) 1.29
Admixture mapping of coronary artery calcified plaque in African Americans with type 2 diabetes mellitus. Circ Cardiovasc Genet (2012) 1.22
Direct inhibition of NF-kappa B blocks bone erosion associated with inflammatory arthritis. J Immunol (2003) 1.21
Vacuolar H+-ATPase binding to microfilaments: regulation in response to phosphatidylinositol 3-kinase activity and detailed characterization of the actin-binding site in subunit B. J Biol Chem (2003) 1.16
Tumor necrosis factor-alpha inhibits pre-osteoblast differentiation through its type-1 receptor. Cytokine (2003) 1.15
Inhibition of p38 mitogen-activated protein kinase prevents inflammatory bone destruction. J Pharmacol Exp Ther (2006) 1.13
Successful treatment of an adynamic bone disorder with bone morphogenetic protein-7 in a renal ablation model. J Am Soc Nephrol (2004) 1.10
Approximating the head-related transfer function using simple geometric models of the head and torso. J Acoust Soc Am (2002) 1.10
Inhibition of cell survival signal protein kinase B/Akt by curcumin in human prostate cancer cells. J Cell Biochem (2003) 1.07
PTEN regulates RANKL- and osteopontin-stimulated signal transduction during osteoclast differentiation and cell motility. J Biol Chem (2002) 1.06
Relationships between calcified atherosclerotic plaque and bone mineral density in African Americans with type 2 diabetes. J Bone Miner Res (2011) 1.06
Inflammasome-independent IL-1β mediates autoinflammatory disease in Pstpip2-deficient mice. Proc Natl Acad Sci U S A (2014) 1.05
Inhibition of inflammatory bone erosion by constitutively active STAT-6 through blockade of JNK and NF-kappaB activation. Arthritis Rheum (2005) 1.04
Resistin induces expression of proinflammatory cytokines and chemokines in human articular chondrocytes via transcription and messenger RNA stabilization. Arthritis Rheum (2010) 1.04
Effects of phosphate binder therapy on vascular stiffness in early-stage chronic kidney disease. Am J Nephrol (2013) 1.03
Dominant-negative IkappaB facilitates apoptosis of osteoclasts by tumor necrosis factor-alpha. J Biol Chem (2003) 1.02
Overexpression of adiponectin receptors potentiates the antiinflammatory action of subeffective dose of globular adiponectin in vascular endothelial cells. Arterioscler Thromb Vasc Biol (2008) 1.02
A comparison study of upper airway among different skeletal craniofacial patterns in nonsnoring Chinese children. Angle Orthod (2010) 1.02
Defective osteoclastogenesis by IKKbeta-null precursors is a result of receptor activator of NF-kappaB ligand (RANKL)-induced JNK-dependent apoptosis and impaired differentiation. J Biol Chem (2008) 1.02
IKKbeta activation is sufficient for RANK-independent osteoclast differentiation and osteolysis. J Bone Miner Res (2010) 1.02
Inhibition of IKK activation, through sequestering NEMO, blocks PMMA-induced osteoclastogenesis and calvarial inflammatory osteolysis. J Orthop Res (2006) 1.01
Adenovirus mediated BMP-13 gene transfer induces chondrogenic differentiation of murine mesenchymal progenitor cells. J Bone Miner Res (2004) 1.01
Myosin X regulates sealing zone patterning in osteoclasts through linkage of podosomes and microtubules. J Biol Chem (2010) 1.01
Rho-dependent Rho kinase activation increases CD44 surface expression and bone resorption in osteoclasts. J Biol Chem (2003) 0.99
The BMP-7-Smad1/5/8 pathway promotes kidney repair after obstruction induced renal injury. J Urol (2011) 0.99
Activation of peroxisome proliferator-activated receptor-gamma inhibits differentiation of preosteoblasts. J Lab Clin Med (2003) 0.98
RANKL is an essential cytokine mediator of polymethylmethacrylate particle-induced osteoclastogenesis. J Orthop Res (2003) 0.97
Bone morphogenetic protein 7 (BMP7) gene polymorphisms are associated with inverse relationships between vascular calcification and BMD: the Diabetes Heart Study. J Bone Miner Res (2009) 0.96
Regulated proteolysis of nonmuscle myosin IIA stimulates osteoclast fusion. J Biol Chem (2009) 0.96
Expression and distribution of HuR during ATP depletion and recovery in proximal tubule cells. Am J Physiol Renal Physiol (2006) 0.95
HuR stabilizes vacuolar H+-translocating ATPase mRNA during cellular energy depletion. J Biol Chem (2005) 0.95
Tropomyosin isoforms localize to distinct microfilament populations in osteoclasts. Bone (2006) 0.95
Na+-dependent phosphate transporters in the murine osteoclast: cellular distribution and protein interactions. Am J Physiol Cell Physiol (2003) 0.95
The urinary response to an oral oxalate load in recurrent calcium stone formers. J Urol (2003) 0.94
Bone morphogenetic protein-7 delays podocyte injury due to high glucose. Nephrol Dial Transplant (2007) 0.93
In vivo administration of calpeptin attenuates calpain activation and cardiomyocyte loss in pressure-overloaded feline myocardium. Am J Physiol Heart Circ Physiol (2008) 0.93
The pathogenesis of osteodystrophy after renal transplantation as detected by early alterations in bone remodeling. Kidney Int (2003) 0.93
Treatment of a murine model of high-turnover renal osteodystrophy by exogenous BMP-7. Kidney Int (2002) 0.93
Bone morphogenetic protein 7: a novel treatment for chronic renal and bone disease. Curr Opin Nephrol Hypertens (2004) 0.91
Tumor necrosis factor-alpha mediates polymethylmethacrylate particle-induced NF-kappaB activation in osteoclast precursor cells. J Orthop Res (2002) 0.90
NFAT2 is an essential mediator of orthopedic particle-induced osteoclastogenesis. J Orthop Res (2008) 0.89
Vascular smooth muscle cells in the pathogenesis of vascular calcification. Circ Res (2009) 0.88
Relationships between serum adiponectin and bone density, adiposity and calcified atherosclerotic plaque in the African American-Diabetes Heart Study. J Clin Endocrinol Metab (2013) 0.88
Tropomyosin 4 regulates adhesion structures and resorptive capacity in osteoclasts. Exp Cell Res (2007) 0.88
Constitutively active canonical NF-κB pathway induces severe bone loss in mice. PLoS One (2012) 0.88
Impediment of NEMO oligomerization inhibits osteoclastogenesis and osteolysis. J Cell Biochem (2009) 0.87
Transcriptional control of human antigen R by bone morphogenetic protein. J Biol Chem (2009) 0.87
Expression of the RNA-stabilizing protein HuR in ischemia-reperfusion injury of rat kidney. Am J Physiol Renal Physiol (2009) 0.86
Polyphosphoinositides-dependent regulation of the osteoclast actin cytoskeleton and bone resorption. BMC Cell Biol (2004) 0.86
Impaired marrow osteogenesis is associated with reduced endocortical bone formation but does not impair periosteal bone formation in long bones of SAMP6 mice. J Bone Miner Res (2004) 0.85
Adaptive and maladaptive expression of the mRNA regulatory protein HuR. World J Biol Chem (2013) 0.85
Bone morphogenetic protein-7: an anti-fibrotic morphogenetic protein with therapeutic importance in renal disease. Curr Opin Nephrol Hypertens (2002) 0.85
Proprotein convertases regulate activity of prostate epithelial cell differentiation markers and are modulated in human prostate cancer cells. J Cell Biochem (2003) 0.84
HuR inhibits apoptosis by amplifying Akt signaling through a positive feedback loop. J Cell Physiol (2013) 0.84
Blockade of JNK and NFAT pathways attenuates orthopedic particle-stimulated osteoclastogenesis of human osteoclast precursors and murine calvarial osteolysis. J Orthop Res (2012) 0.84
Down-regulation of miR-21 biogenesis by estrogen action contributes to osteoclastic apoptosis. J Cell Biochem (2013) 0.84
Relationships between serum MCP-1 and subclinical kidney disease: African American-Diabetes Heart Study. BMC Nephrol (2012) 0.84
Systems level analysis of osteoclastogenesis reveals intrinsic and extrinsic regulatory interactions. Dev Dyn (2007) 0.83
High molecular weight tropomyosins regulate osteoclast cytoskeletal morphology. Bone (2008) 0.83
Sclerostin is positively associated with bone mineral density in men and women and negatively associated with carotid calcified atherosclerotic plaque in men from the African American-Diabetes Heart Study. J Clin Endocrinol Metab (2013) 0.82
Tyrosine phosphorylation is required for IkappaB kinase-beta (IKKbeta) activation and function in osteoclastogenesis. J Biol Chem (2010) 0.82
Lysine392, a K63-linked ubiquitination site in NEMO, mediates inflammatory osteoclastogenesis and osteolysis. J Orthop Res (2011) 0.82
Human umbilical cord blood-derived CD34+ cells reverse osteoporosis in NOD/SCID mice by altering osteoblastic and osteoclastic activities. PLoS One (2012) 0.82
Clinical phenotype of APOL1 nephropathy in young relatives of patients with end-stage renal disease. Pediatr Nephrol (2014) 0.82
Left ventricular mass progression despite stable blood pressure and kidney function in stage 3 chronic kidney disease. Am J Nephrol (2014) 0.81
Expression of DGCR8-dependent microRNAs is indispensable for osteoclastic development and bone-resorbing activity. J Cell Biochem (2014) 0.81
Endogenous BMP-7 is a critical molecular determinant of the reversibility of obstruction-induced renal injuries. Am J Physiol Renal Physiol (2011) 0.81
In vivo transplantation of neonatal ovine neocartilage allografts: determining the effectiveness of tissue transglutaminase. J Knee Surg (2005) 0.81
Regulation of enhanced vacuolar H+-ATPase expression in macrophages. J Biol Chem (2002) 0.81
Polyubiquitination events mediate polymethylmethacrylate (PMMA) particle activation of NF-kappaB pathway. J Biol Chem (2011) 0.81
c-Src-mediated phosphorylation of thyroid hormone receptor-interacting protein 6 (TRIP6) promotes osteoclast sealing zone formation. J Biol Chem (2010) 0.79
Krüppel-like factor 4 is induced by rapamycin and mediates the anti-proliferative effect of rapamycin in rat carotid arteries after balloon injury. Br J Pharmacol (2012) 0.78
The Kidney-Vascular-Bone Axis in the Chronic Kidney Disease-Mineral Bone Disorder. Transplantation (2016) 0.78
Krüppel -like factor 8 is a stress-responsive transcription factor that regulates expression of HuR. Cell Physiol Biochem (2014) 0.78
Regulation of NF-κB signaling in osteoclasts and myeloid progenitors. Methods Mol Biol (2015) 0.77
Ubiquitin-like domain of IKKβ regulates osteoclastogenesis and osteolysis. Calcif Tissue Int (2013) 0.76
Functional vacuolar ATPase (V-ATPase) proton pumps traffic to the enterocyte brush border membrane and require CFTR. Am J Physiol Cell Physiol (2013) 0.76
In vitro culture and directed osteogenic differentiation of human pluripotent stem cells on peptides-decorated two-dimensional microenvironment. ACS Appl Mater Interfaces (2015) 0.76
Mechanosignaling in bone health, trauma and inflammation. Antioxid Redox Signal (2013) 0.76